The Monte Carlo N-Particle radiation transport computer code (MCNP) has been employed on a personal computer to develop a simple model simulating the major components within the beam path of a linear accelerator radiation head, namely the electron target, primary conical collimator, beam flattening filter, wedge filter and the secondary collimators. The model was initially used to calculate the energy spectra and angular distributions of the x-ray beam for the Philips SL 75/5 linear accelerator, in a plane immediately beneath the flattening filter. These data were subsequently used as a 'source' of x-rays at the target position, to assess the emergent beam from the secondary collimators. The depth dose distributions and dose profiles at constant depth for various field sizes have been calculated for a nominal operating potential of 4 MV and found to be within acceptable limits. It is concluded that the technique may be used to calculate the energy spectra of any linear accelerator upon specification of the component dimensions, materials and nominal accelerating potential. It is anticipated that this work will serve as the basis of a quality control tool for linear accelerators and treatment planning systems.
The design and construction of a versatile clinical instrument for multi-element in vivo neutron activation analysis of major and minor body elements is described. A 200 micrograms (4 GBq) 252Cf neutron source is stored below ground level and pneumatically propelled to one of two irradiation ports. These deliver collimated beams of fast neutrons either to a localised volume such as the liver or kidney, or across the width of a patient for a head-to-toe scanning whole-body measurement. The source control system allows selection of either a continuous or cyclic mode of activation. The instrument is intended primarily for measurement, by the prompt-gamma technique, of total and partial body calcium, total body nitrogen and partial body cadmium. The potential of the instrument for determination of these three elements has been established. Phantom results suggest that total body calcium can be measured with a precision of +/- 2.6% (CV) for an average whole-body skin dose equivalent of 6.4 mSv; total body nitrogen with a precision of +/- 2.0% for an average whole-body skin dose equivalent of less than 0.4 mSv; and a detection limit (2 SD of the background) of 2.4 mg of cadmium in the kidney has been obtained for a radiation dose equivalent to the skin of 3 mSv (QF = 10). The suitability of this instrument for the measurement of other elements is also discussed.
Percutaneous oestradiol replacement therapy prevents menopausal bone loss and is associated with a sustained and significant increase in total body calcium, spinal trabecular bone mineral density and radial bone mineral content over a 3-year treatment period. Oestradiol implants thus have skeletal effects comparable to those of oral or transdermal oestrogens.
A novel clinical instrument for multi-element in vivo neutron activation analysis has been recently constructed in Swansea. The instrument is intended primarily for prompt gamma measurement of total and partial body calcium, total body nitrogen and partial body cadmium. For the measurement of nitrogen the subject is scanned both prone and supine across a vertical collimated neutron beam from a 4 GBq 252Cf source. Two shielded Nal(TI) detectors, each of volume 2760 cm3, are placed above the subject on the opposite side to that irradiated. The prompt gamma ray spectrum contains prominent peaks from hydrogen, nitrogen, chlorine and carbon. The optimisation, calibration and evaluation of the instrument for the measurement of nitrogen, by the reaction 14N(n, gamma)15N, is described. The calibration corrects the ratio of nitrogen-to-hydrogen counts measured from the subject for background gamma rays and the effects of body habitus. Body hydrogen is use as as internal standard. Repeated measurements of a homogeneous anthropomorphic phantom indicate that the ratio of nitrogen-to-hydrogen counts may be determined by a coefficient of variation of 1.6% for a neutron dose equivalent incident on the phantom of 0.45 mSv (QF = 10). The accuracy of the calibration was assessed by measuring three anthropomorphic phantoms (weight range: 41.4-110 kg) containing simulated skeletons and the major organs of the body. For these phantoms the mean discrepancy of the measured to the known nitrogen content was +4.9%. The simultaneous measurement of chlorine and carbon is discussed.
Radiotherapy treatments are becoming more complex, often requiring the dose to be calculated in three dimensions and sometimes involving the application of non-coplanar beams. The ability of treatment planning systems to accurately calculate dose under a range of these and other irradiation conditions requires evaluation. Practical assessment of such arrangements can be problematical, especially when a heterogeneous medium is used. This work describes the use of Monte Carlo computation as a benchmarking tool to assess the dose distribution of external photon beam plans obtained in a simple heterogeneous phantom by several commercially available 3D and 2D treatment planning system algorithms. For comparison, practical measurements were undertaken using film dosimetry. The dose distributions were calculated for a variety of irradiation conditions designed to show the effects of surface obliquity, inhomogeneities and missing tissue above tangential beams. The results show maximum dose differences of 47% between some planning algorithms and film at a point 1 mm below a tangentially irradiated surface. Overall, the dose distribution obtained from film was most faithfully reproduced by the Monte Carlo N-Particle results illustrating the potential of Monte Carlo computation in evaluating treatment planning system algorithms.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.